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Abstract,  Human fibroblasts have a  limited replicative 
life span when maintained in culture after which they 
become unresponsive to treatment with mitogens, a 
phenomenon most commonly called senescence. Ex- 
periments indicating that serum does not induce ex- 
pression of the c-fos proto-oncogene in senescent fibro- 
blasts raised the issue of a potential central role for 
c-fos in the phenotype of sustained growth arrest.  This 
was directly tested by microinjection of oncogenic 
c-Ha-ms protein into senescent fibroblasts. While ras 
injection was found to induce marked nuclear c-fos ex- 
pression and functional AP-1 transcription activity, this 
did not lead to DNA synthesis. These results suggest 
that the senescence phenotype cannot be solely attrib- 
uted to the absence of c-fos expression and that the 
proliferative block in these cells is either independent 
of AP-1 transcriptional activity, downstream of it, or 
involves multiple molecular mechanisms. 
SSENTIALLY all eukaryotic cells demonstrate a finite 
capacity for cell division when serially passaged in 
vitro (Hayflick and Moorhead, 1961). This phenom- 
enon, referred to as cellular senescence, is characterized by 
maintenance of viability and metabolism in the presence of 
sustained cell cycle arrest  (reviewed in Goldstein,  1990; 
McCormick and Campisi,  1991). Because cultured fibro- 
blasts taken from young individuals are capable of a greater 
number of population doublings than cells from older sub- 
jects, cellular senescence is considered to reflect and con- 
tribute to the aging process of the organism. 
Recent studies have addressed the molecular basis for the 
block to proliferation in senescent cells. Comparison of the 
expression of  cell cycle dependent genes in early passage and 
senescent fibroblasts reveals that growth arrest in the latter 
occurs near the G1/S boundary of the cell cycle just before 
the onset of DNA synthesis (Rittling et al., 1986). Senescent 
fibroblasts exhibit a highly attenuated growth response fol- 
lowing addition of serum or a variety of purified growth fac- 
tors despite the presence of normal numbers of growth factor 
receptors (Goldstein and Shmookler Reis,  1985). 
In presenescent fibroblasts rendered quiescent by serum 
deprivation, stimulation by mitogenic growth factors results 
in the rapid expression of the proto-oncogenes c-fos  and 
c-myc, and an increased expression of c-ras, before the onset 
of proliferation (Greenberg and Ziff, 1984;  Muller et al., 
1984;  Lu et al.,  1989).  Expression of all three genes has 
been shown to be essential for the initiation of DNA synthe- 
sis (Holt et al., 1986; Heikkila et al., 1987; Mulcahy et al., 
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1985;  Riabowol et al.,  1988).  Similar studies conducted 
using senescent human fibroblasts have shown that while 
c-myc and c-ras are expressed in response to mitogen treat- 
ment (Rittling et al., 1986), c-fos appears repressed as a re- 
sult of a specific transcriptional block (Seshadri and Cam- 
pisi,  1990).  On the basis of this observation, it has been 
suggested that an inherent mechanistic difference exists be- 
tween the responses of presenescent and senescent cells to 
treatment with serum, and that the lack of c-fos transcription 
may account for the failure of the latter to proliferate (Gold- 
stein, 1990; McCormick and Campisi, 1991). Evidence for 
a central role for c-fos in the senescent phenotype is thus in- 
direct and derived from the observation of a deficiency in ex- 
pression of the proto-oncogene in senescent cells. A more 
direct test of this hypothesis is therefore important. 
Here, we describe an experimental approach which allows 
a  direct  assessment of the  potential  role  of c-fos  in  the 
proliferation of senescent fibroblasts.  Through direct micro- 
injection of human Ha-ras oncogene protein (T-24 ras) into 
senescent human fibroblasts, we find that c-fos is rapidly ex- 
pressed.  Moreover, by coinjection of a reporter gene con- 
struct containing an  AP-1 regulated promoter,  we  deter- 
mined that the c-fos protein expressed in these cells was 
likely to be active as the senescent ceils injected with the ras 
protein  efficiently expressed  the  AP-1 regulated  reporter 
gene. The injected cells, however, failed to progress through 
S-phase of  the cell cycle as detected by a lack of  DNA synthe- 
sis. These results suggest that expression of c-fos, and active 
AP-1 transcription factor, is not sufficient to relieve the cell 
cycle block in senescent human fibroblasts. 
The  mammalian ms  proto-oncogene family consists of 
three members,  c-Ha-ras,  c-Ki-ras,  and c-N-ras,  each of 
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tions at discrete locations in their coding sequences (Tabin 
et al.,  1982),  or by overexpression (Wigler et al.,  1984). 
Microinjection  of  oncogenic  ras  protein  into  quiescent 
fibroblasts has been shown to result in changes in cell mor- 
phology (Feramisco et al., 1984), induction of c-fos expres- 
sion (Stacey et al., 1987), and initiation of DNA synthesis. 
In contrast, senescent human fibroblasts injected with onco- 
genic c-Ha-ms expression vectors (Lumpkin et al.,  1986) 
fail to synthesize DNA. Transformation of cycling or quies- 
cent fibroblasts by microinjected Ha-ras proteins proceeds 
temporally,  with  stimulation  of  membrane  ruffling  and 
pinocytosis within 30-90  min postinjection, induction of 
c-fos expression within 1-2 h, and increased DNA synthesis 
within 24 h. We sought to determine which identifiable com- 
ponents of the oncogenic ras proliferative program were ac- 
tive in senescent human fibroblasts. 
Materials and Methods 
Cell Culture 
Human fetal lung fibroblasts (IMR-90 cells) were maintained at 37~  in a 
humidified incubator under a 5% CO2 atmosphere in DME/high glucose 
(Gibeo  Laboratories,  Grand Island,  NY)  supplemented with  10%  FBS 
(Gemini Bioproducts, Inc., Caiabasas,  CA) and penicillin/streptomycin. 
Senescent cells were generated from late passage human fetal lung fibro- 
blasts, IMR-90 cells, which became nonproliferative after 47-55 population 
doublings during serial passage in vitro (Adler et al., 1991). Typically 5-7 % 
of  these cells were capable of DNA synthesis  as compared to '~  % of early 
passage cells defined by <20 population doublings. An additional opera- 
tional  criterion  for  senescence was  that  the  cells  could  not  grow  to 
confluence 4 wk after their final passage. Cells were grown initially on plas- 
tic dishes and were then prepared for microinjection by trypsinization and 
replating on sterile glass acid-washed coverslips at subconfluent  density. Be- 
fore injection, early passage and senescent fibroblasts were plated sep- 
arately at equal density and rendered quiescent by incubation in DME sup- 
plemented with 0.5% serum for at least 36 h. Under these conditions, the 
proliferating fraction in both early and late passage cultures was <7%. 
Microinjection 
The following samples and concentrations were used in microinjection ex- 
periments: oncogenic "1"-24 ras protein, at a  final  concentration of "01.0 
mg/ml, resulting in the introduction of 10~-106 molecules per cytoplasmi- 
cally injected cell. The ras protein was purified from an F~cherichia coli 
expression vector system (Gross et al., 1985) to near homogeneity as in Fer- 
amisco et al.  (1984).  Inert carrier IgG (Sigma Chemical Co., St.  Louis, 
MO) was coinjected with all samples at a concentration of 2 mg/ml to allow 
the definitive identification of all microinjected cells. The coinjected IgG 
used was either murine or rabbit depending upon the particular experiment. 
Control injections of  carrier IgG alone were carried out in all cases and were 
found not to affect any of the assays described below. In experiments involv- 
ing the use of expression vectors, the purified 4XTRE/IacZ plasmid or the 
5XCRE/lacZ plasmid (Meinkoth et al., 1990) were used at a final concen- 
tration of 0.5 mg/ml and nuclear microinjections were performed. In these 
cases, smaller amounts of protein were injected into the nuclei, however, 
some spillover into the cytoplasm was routinely observed. 
Samples were microinjected into  IMR-90 cells at  room temperature 
using an  Eppendorf microinjector (model 5242,  Brinkman Instruments 
Inc., Westbury, NY) attached to an Eppendorf micromanipulator (model 
5170 or 5171) and an inverted microscope (Carl Zeiss, Oberkochen, Ger- 
many). Samples were loaded into Eppendorf Femtotips using Microloader 
pipette tips. Injections were performed with a typical needle pressure of 
"0120 hPa for cytoplasmic injections and about 75 hPa for nuclear injec- 
tions. 
Staining and Fluorescence Microscopy 
To examine morphological effects of oncogenic ms protein microinjection, 
early passage and senescent IMR-90 cells were injected with either murine 
IgG alone or with IgG and T-24 ms. After 3 h of incubation at 37"C, the 
cells were fixed for 30 min in 95 % ethanol, 5 % acetic acid and then stained 
to visualize the distribution of coinjected IgG. Microinjected murine IgG 
was detected using HRP-conjngated rabbit anti-mouse IgG  (Amersham 
Corp.,  Arlington Heights, IL)  followed by 3,3' diaminobenzidine tetra- 
hydrochloride as substrate. Coverslips were permanently mounted on glass 
microscope slides for analysis. 
To quantitate DNA synthesis in injected cells, a solution of 5-bromo-2'- 
deoxyuridine (BrdU) l (Amersham Corp., cell proliferation kit) was added 
to the culture medium for 24 h after microinjection. After labeling, cover- 
slips were washed in PBS, and the cells were then fixed in 3.7 % formalde- 
hyde in PBS and incubated with a monoclonal rat antibody against BrdU 
(Accurate Chemical and Scientific Corp., Westbury, NY).  The antibody 
was diluted in a solution of 0.5% NP-40 in PBS containing 1,000 units/ml 
of DNAse I (Sigma Chemical Co.),  10 mM MgCI2,  and 5 mg/ml BSA. 
Staining was visualized using rhodamine-conjugated donkey anti-rat IgG 
(Jackson Immunoresearch Laboratories, Inc., West Grove, PA).  Microin- 
jected cells were detected by staining with a  fluorescein isothiocyanate- 
conjugated horse anti-rabbit IgG (Cappel Laboratories, Cochranville, PA). 
Expression of c-fos protein was detected by staining with a polyclonai anti- 
body to human c-fos (Oncogene Science, Inc., Manhasset, NY) followed 
by sequential use of  biotinylated horse anti-rabbit IgG (Vector Laboratories, 
Burlingame, CA) and streptavidin-conjugated  Texas red (Amersham Corp.). 
The anti-fos antibody is specific for c-fos and other fos family members. 
In experiments measuring transcriptional activity  from microinjected 
reporter plasmids, nuclei of IMR-90 cells were injected with mixtures of 
carrier IgG and the appropriate expression vector either in the absence or 
presence of  T-24 ms protein. To test for the presence of AP-1 (los dependent) 
transcriptional activity, the 4XTRE/lacZ construct (Meinkoth et al., 1990) 
was used. As a control, the 5XCRE/IacZ expression vector was microin- 
jected in parallel. 6 h after injection, cells were fixed and stained overnight 
with the chromogenic substrate 5-bromo-4-chloro-3-indolyl-/~-D-galacto- 
side (Xgal) to detect/3 galactosidase expression. To insure the activity of 
the vector,  duplicate  injections of the  5XCRE/IacZ  plasmid  were per- 
formed, and the cells were treated with 1 mM 8-bromo-cAMP and 1 mM 
isobutylmethylxanthine for 3 h before staining. In all cases, injected cells 
were detected by staining with fluorescein isothiocyanate-conjugated rabbit 
anti-mouse IgG (Cappel Laboratories). All injection experiments described 
were performed a minimum of three separate times. Cells were viewed and 
results analyzed on an Axiophot epifluorescence microscope (Carl Zeiss) 
equipped with fluorescein and rhodamine fluorescence filters. Photomicro- 
graphs were taken on Technical Plan 100 film (phase contrast) or T-Max 
400 film for fluorescence (Eastman Kodak Co., Rochester, NY). 
Results 
ras-lnduced Morphological Changes 
Microinjection of T-24 ras protein into senescent fibroblasts 
resulted  in  membrane-associated  morphological  changes 
within a short period of time, which became obvious with 
immunohistochemical  staining  within 2-4  h  (Fig.  1).  In- 
creased membrane ruffling,  closely associated with pinocy- 
tosis, has been shown previously to be an integral part of the 
ms-induced proliferative process (Bar-Sagi  and Feramisco, 
1986). Similar cell surface ruffling and fluid-phase pinocyto- 
sis,  although  less distinct and  sustained,  occur before the 
mitogenic effect of serum or purified growth factors upon 
cells maintained in serum-free medium (Myrdal and Auers- 
perg,  1986).  The majority of ras protein-injected cells ex- 
hibited grossly observable cytoplasmic vacuolation.  Senes- 
cent cells which were injected with carrier IgG alone for 
comparison purposes did not exhibit observable effects from 
the  microinjection  process  (Fig.  1).  These  cell  surface 
changes seen in senescent fibroblasts  injected with T-24 ras 
protein provided  evidence  that  at  least  some of the  early 
1. Abbreviations used in this paper: BrdU, 5-bromo-2'-deoxyuridine; Xgal, 
5-bromo-4-chloro-3-indolyl-/~-o-galactoside. 
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Oncogenic H-ras Microinjection  in IMR-90 Cells 
c-fos expression  BrdU incorporation 
Protein 
injected  Presenescent  Senescent  Presenescent  Senescent 
(% of cells injected) 
T-24 ras  71  (92/129)*  62 (95/154)  77  (85/111)  5  (7/127) 
IgG alone  10, (141136)  10 (12/117)  3  (4/122)  2  (2/99) 
* Numbers in parenthesis indicate total  numbers of cells scored positive for 
c-fos expression or DNA synthesis relative to total number of cells injected. 
r microinjection of control protein resulted in weak nuclear c-fos staining in 
a small percentage of cells. This staining was not as intense as that seen when 
ras protein was injected. 
Figure 1. Morphological changes occur in senescent human fibro- 
blasts as a result of oncogenic H-ras microinjection. Subconfluent 
IMR-90 cells were cultured on glass coverslips and microinjected 
with either T-24 ras protein (b) (containing carder IgG for detec- 
tion purposes) or with IgG alone (a). 3 h after injection, the cells 
were fixed and stained to visualize the distribution of injected IgG. 
Phase contrast, scale bar, 25/zm. 
components of the proliferative process were intact, and that 
the block in proliferation was therefore either independent of 
these phenotypic changes or downstream of them. In addi- 
tion, the morphological changes demonstrated the biological 
activity of the ms protein in this cell line. This observation 
raised the question of whether ms-mediated induction of 
c-fos expression, observed in quiescent presenescent fibro- 
blasts, also occurs in senescent cells. 
ras-Induced fos Protein Expression 
To evaluate the expression of  c-fos after the injection of  onco- 
genic ms protein, senescent fibroblasts were injected with 
ras protein and subsequently were stained simultaneously 
for the presence of coinjected carrier IgG and for the pres- 
ence of c-fos protein in the nucleus of injected cells. The use 
of two different fluorescent probes allowed simultaneous de- 
tection of injected cells and c-fos  expression in those in- 
dividual cells (Fig. 2). In addition, a parallel set of microin- 
jected  cells  were  processed  for  the  incorporation of the 
thymidine analog BrdU to identify cells which entered S 
phase of the cell cycle. The results demonstrated (Table I) 
that the majority of the serum-starved early passage fibro- 
blasts synthesized DNA after ms injection whereas only a 
rare cell in senescent populations was found to incorporate 
BrdU.  Unexpectedly, injected ms protein induced a strong 
positive signal for c-los  in the majority of nuclei in both 
presenescent and senescent fibroblasts (Fig. 2). Because the 
majority of ms-injected senescent cells expressed c-fos pro- 
'tein while few cells synthesized DNA under the same condi- 
tions, it appears clear that expression of c-fos in these cells 
was not sufficient to stimulate DNA synthesis. 
AP-1 Dependent Gene Expression in Senescent Cells 
Because members of the c-fos family form complexes with 
members of  the c-jun family, constituting the family of trans- 
acting transcription factors, AP-1, it was of importance to at- 
tempt to determine if senescent ceils injected with the ras 
oncogene protein contained functional AP-1 transcription 
factor. This may be of particular importance in senescent 
cells, because AP-1 is known to play a role in the transcrip- 
tional regulation of  a variety of  cellular genes, many of  which 
are subject to control by signals for growth or transformation 
(Lee et al.,  1987a,b;  Piette and Yaniv, 1987; Angel et ai., 
1987; Franza et al.,  1988).  To test this possibility, reporter 
constructs  containing  the  E.  coli  lac-Z  gene  fused  to 
promoters containing either AP-1 (TRE), or cAMP-respon- 
sive (CRE), regulatory sequences (Meinkoth et al.,  1990; 
1991) were assayed for expression of #-galactosidase in the 
senescent cells after coinjection with the ras protein or con- 
trol protein. Previous studies demonstrated that microinjec- 
tion of the ms protein into cell lines stably transfected with 
these  reporter  genes  induces  B-galactosidase  expression 
from promoters containing AP-1 binding sites but not CRE 
sequences (D. Rose, manuscript in preparation). While it has 
not been directly proven that the injected ras protein acti- 
vates transcription of the AP-1 regulated reporter gene via a 
functional AP-I protein complex containing fos and jun,  it 
is likely that this is indeed the case (Chiu et al., 1988). Thus, 
these experiments would test whether or not senescent cells 
were capable of showing enhanced transcription of an AP-1 
reporter construct after oncogenic ras injection. Both pre- 
senescent and senescent cells coinjected with ras protein and 
the TRE-lac Z plasmid exhibited efficient  1~ gaiactosidase ex- 
pression (Fig. 3). The cells expressed detectable/3-gaiactosi- 
dase as early as 3 h postinjection, and required active ms 
protein in addition to the construct for this expression. In 
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 Table II. Beta Galactosidase Expression as a Result of 
Coinjection of Oncogenic H-ras and p TRE/lacZ Plasmid 
in IMR-90 Cells 
#-galactosidase expression 
Sample injected  (% of cells injected) 
Presenescent  Senescent 
pTRE/lacZ  6 (15/268)*  5  (14/283) 
pTRE/IacZ and T-24 ras  78  (204/263)  70 (217/312) 
pCRE/IacZ  4  (12/276)  4  (9/248) 
pCRE/IacZ*  78  (258/331)  82  (207/253) 
pCRE/lacZ and T-24 ras  5  (12/267)  5 (13/247) 
* Numbers in parenthesis indicate total numbers of cells expressing O-galac- 
tosidase relative to the total number of cells injected. 
~: after microinjection, cells were treated for 6 h with 8-bromo-cAMP and 
isobutylmethyxanthine. 
contrast, neither type of cell expressed the marker enzyme 
when the CRE-lacZ reporter construct was coinjected with 
ras protein. The activity of the CRE-IacZ plasmid was con- 
firmed by duplicate microinjections followed by treatment of 
the cells with 8-bromo-cAMP and isobutylmethylxanthine 
(Table II). These results suggested that while senescent cells 
injected with the ras protein show enhanced AP-1 dependent 
gene expression, not all types of transcription factors (i.e., 
cAMP response element binding protein) are thus activated. 
The results document the presence in senescent cells of ac- 
tive AP-1 transcriptional activity specific for a TRE-contain- 
ing regulatory element in response to oncogenic ras protein 
microinjection. Thus, while this activity has recently been 
shown to be decreased in mitogen-stimulated human fibro- 
blasts as the cells age (Riabowol et al.,  1992), injection of 
ras protein appears to generate a sufficient amount of active 
AP-1 to give rise to reporter activity. 
Discussion 
Evidence for a causative role of c-fos in the senescent pheno- 
type has been, to date, the observation of a deficit of its ex- 
pression in senescent cells. Considering the potential impor- 
tance of this possibility,  we  sought a  direct experimental 
approach to test the role of c-fos by attempting to induce the 
expression of the protein in an intact cellular context￿9 Using 
an  assay  which  permits  examination  of effects upon  in- 
dividual cells, we have investigated the role ofc-fos in senes- 
cent  cell  growth  control.  Expression  of the  c-fos  proto- 
oncogene is  an  essential  prerequisite for the  initiation of 
DNA synthesis m qmescent fibroblasts stimulated with se- 
rum. Senescent human fibroblasts do not express c-fos, how- 
ever, in response to serum treatment (Seshadri and Campisi, 
1990), despite the observation that these cells appear to ex- 
press and regulate a number of other genes in a manner typi- 
cal of fibroblasts. If the observed repression of c-fos expres- 
sion were the primary defect in senescent cells, one would 
anticipate that its expression would restore the proliferative 
potential of the cells, particularly in the presence of a strong 
replicative signal such as oncogenic ms. The present results, 
expression of c-fos protein in the absence of DNA synthesis, 
appear to indicate that this is not the case. Recent results ob- 
tained by others (Surmacz et al., submitted for publication) 
lead to a similar conclusion. Moreover, the present results 
appear to indicate that while senescent cells are capable of 
enhanced expression of indicator constructs  regulated by 
AP-1 promoter sequences when they are coinjected with on- 
cogenic ras protein, this increased activity, presumably a 
downstream effect of increased c-fos expression (Schonthal 
et al., 1988) is not sufficient to alleviate the block in the cell 
cycle of senescent cells. Thus, c-fos expression is likely to 
be necessary but not sufficient for the proliferation of these 
cells (Surmacz et al.,  submitted for publication)￿9 
These results support the view that senescent cells do not 
fail to proliferate because of an inherent inability to trans- 
duce these early stimulatory signals for growth.  Senescent 
cells  possess  apparently  normal  growth  factor  receptors 
(Goldstein and Shmookler Reis,  1985)￿9 The generation of 
transcriptionally active AP-1 following injection of onco- 
genic ras protein into senescent ceils indicates that at least 
some of the intracellular signaling pathways are operative. It 
is still possible that the arrest to growth in senescent cells 
is due to the selective repression of one or several normal 
responses to signals for growth. Microinjection of oncogenic 
ras protein apparently provides a positive signal of sufficient 
intensity to overcome the repression of c-fos.  This result is 
of interest in and of itself in view of  the general lack of induc- 
tion of c-fos expression by serum. One possible explanation 
for this is that injected ras oncogene proteins, which cause 
an exaggerated ruffling response in comparison to the re- 
sponse seen for serum treatment, overcome a putative block 
in the normal signaling process associated with the growth 
factor receptors in the plasma membrane. As it appears that 
purified mitogens may also induce c-fos expression to some 
extent in senescent cells (Paulsson et al.,  1986), this possi- 
bility seems plausible￿9 
Another potential underlying mechanism  in  senescence 
involves the regulation of the retinoblastoma susceptibility 
gene product (Rb). The Rb protein is thought to function in 
a growth-inhibitory manner in normal cells. It is found in a 
hypophosphorylated state in quiescent cells, and it is thought 
that  traversion of the  G1/S  cell cycle boundary,  allowing 
DNA  synthesis  to  occur,  is  dependent  upon  the  hyper- 
phosphorylation of the  protein  (Mihara  et al.,  1989).  In 
senescent cells, this phosphorylation does not occur (Stein 
et al.,  1990)￿9 Additionally, SV40 T antigen, which preferen- 
tially binds to and is thought to inactivate the hypophosphor- 
ylated form of the Rb protein, also induces DNA synthesis 
when introduced into senescent cells (Wright et al.,  1989; 
Radna et al.,  1989) and induces c-fos expression (Surmacz 
et al. submitted for publication)￿9 In the 5' promoter region 
of the c-fos gene, a negative-acting Rb response element has 
recently been identified (Robbins et al.,  1990). It is not cur- 
rently known whether the phosphorylation state of the Rb 
protein has any effect upon its ability to influence the expres- 
sion of the c-fos gene, or whether such a mechanism is oper- 
ative during senescence. We are currently in the process of 
evaluating the regulation of the Rb protein in response to 
microinjection of oncogenic ras protein. It is clear, however, 
from results presented here that if in fact the phosphorylation 
state of the Rb protein is a determining factor in the lack of 
progression from G1 to S phase in senescent cells, it appears 
not to be the mechanism responsible for repression of c-fos 
expression.  Because microinjection of ras  protein affects 
c-fos  protein expression but  not  DNA  synthesis,  the  two 
Rose et al. Senescent Cell Expression of AP-I Activity  1409 events appear to be independently regulated.  Events down- 
stream or parallel to c-fos expression deserve particular at- 
tention in future efforts to explain the molecular nature of the 
senescent state. 
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Figure 3. Microinjection of oncogenic H-ras results in functional AP-1 activity in presenescent and senescent human fibroblasts.  Nuclei 
of presenescent (a, c, e) or senescent (b, d, f) IMR-90 cells were injected with a mixture of carrier IgG and 4X TRE/lacZ expression 
vector (Meinkoth, et al.,  1990) either in the absence (a-d) or presence (e, f) of added  T-24  ms protein. 6  h later,  all cells were fixed 
and stained with the chromogenic substrate  Xgal to detect/3 galactosidase expression and also stained for injected protein. Fluorescence 
photomicrographs demonstrate which of the cells in c and d have been microinjected; the corresponding phase contrast pictures demonstrate 
the ms-dependence of/~ galactosidase expression (the lack of blue staining in c and d) and the presence of AP-1 transcriptional  activity 
in cells which have been injected with ms protein, regardless of the age of the cells. 
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